CSI Market
Sign In | Register

Crispr Therapeutics Ag (CRSP) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CRSP Annual Balance Sheets →
Balance sheet patterns shown here provide context for understanding Crispr Therapeutics Ag's financial stability and long-term positioning.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent423.31
Marketable Securities, Current SH2,018.48
Cash & Short-term Investments2,441.00
Prepaid Expense And Other Assets Current6.58
Total Current Assets2,448.36
Equipment/Property/Plant Net112.18
Long-term investments0.00
Other Assets, Noncurrent165.28
Restricted Cash Noncurrent7.63
Operating Lease Right Of Use Asset128.67
Total Assets2,725.82
Liabilities
Accounts Payable, Current AC13.65
Accrued Liabilities, Current AC74.93
Other Liabilities, Current47.07
Taxes Payable, Current, Total0.64
Total Current Liabilities136.29
Long-term debt585.47
Total Long-term Debt585.47
Other liabilities, Noncurrent189.51
Contract With Customer Liability Current15.34
Contract With Customer Liability Noncurrent-
Operating Lease Liability Noncurrent183.56
Total Liabilities911.26
Stockholders' Equity
Common Stock Value3.12
Treasury Stock Value-0.06
Additional Paid In Capital Common Stock3,883.92
Retained Earnings / Accumulated Deficit-2,070.48
Other Equity-1.94
Common Stockholder's Equity1,814.56
Total Stockholder's Equity1,814.56
Liabilities & Stockholder's Equity2,725.82
4 historic quarters locked

Sign in to unlock the full Crispr Therapeutics Ag balance sheet history.

Sign In Create Free Account

About Crispr Therapeutics Ag Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-330672

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.